BioSpace News Archive

Biotech Bay

ASC Therapeutics and Vigene Announce Long-Term Strategic Partnership for Gene Therapy Development and Manufacturing

ASC Therapeutics, a privately-held gene therapy company focused on developing transformative gene-based medicines for serious diseases, announced that it has entered into a long-term strategic manufacturing partnership with Vigene Biosciences, a Maryland-based Contract Develop and Manufacturing Organization.

January 14, 2020
·
3 min read
Deals

Mirati Therapeutics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters’ Option To Purchase Additional Shares - Jan. 14, 2020 - Jan. 14, 2020

Mirati Therapeutics, Inc. announced the closing of its previously announced underwritten public offering of 3,538,462 shares of its common stock at a public offering price of $97.50 per share.

January 14, 2020
·
3 min read
Business

Rockwell Medical, Inc. Enters into Exclusive License and Supply Agreements with Sun Pharma for the Rights to Commercialize Triferic® in India- Sizable and growing market opportunity with 120,000+ patients receiving hemodialysis annually –

Rockwell Medical, Inc. announced that it has entered into license and supply agreements with a wholly-owned subsidiary of Sun Pharmaceutical Industries Ltd., for the rights to commercialize Triferic in India.

January 14, 2020
·
7 min read
BioCapital

ALS Association Makes Multi-Year Commitment to HEALEY ALS Platform Trial

The ALS Association announced a $3 million commitment to the first platform trial for ALS, taking place at the Sean M. Healey & AMG Center for ALS at Mass General in collaboration with the Barrow Neurological Institute and the Northeast ALS Consortium.

January 14, 2020
·
4 min read
Deals

Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option

Aptinyx Inc. announced the closing of its public offering of 11,691,666 shares of its common stock, which included the exercise in full of the underwriters’ option to purchase additional shares, at a public offering price of $3.00 per share.

January 14, 2020
·
3 min read
Deals

Rosalind Franklin University Incubator Gains Support from Horizon Therapeutics

Rosalind Franklin University of Medicine and Science announced that its new Helix 51 incubator has garnered corporate support from Horizon Therapeutics.

January 14, 2020
·
4 min read
Business

Integra LifeSciences Announces Preliminary Fourth Quarter and Full-Year 2019 Revenue Results and 2020 Financial Guidance

Fourth quarter 2019 reported revenue is expected to be at or near the low end of the previously communicated guidance range of $395 to $400 million, representing organic revenue growth of slightly less than 5% and reported growth of approximately 3%;

January 14, 2020
·
8 min read
Business

Northern California Spine Surgeon Dr. Kornelis Poelstra Leads Spinal Breakthrough with Implantation of First Molybdenum Rhenium Fusion on West Coast

This patented superalloy has greater strength and scratch and fatigue resistance compared to titanium, cobalt and iron alloys.

January 14, 2020
·
2 min read
Business

Acacia Pharma enters into strategic in-licensing, investment and loan transaction with Cosmo Pharmaceuticals N.V.

• Acacia Pharma has in-licensed exclusive US rights to ultra-short-acting sedative, ByFavo™ (remimazolam) from Cosmo adding to its portfolio of near-market products • Cosmo will make a €10 million equity investment in Acacia Pharma and provide a new €35 million loan facility to support commercial activities

January 14, 2020
·
8 min read
Domain Therapeutics secures €6 million ($6.7M) debt financing

GPCR company will expand proprietary portfolio and prepare next financing round

January 14, 2020
·
2 min read